[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365404-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365404-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","twenty-five-years-of-wwox-insight-in-cancer-a-treasure-trove-of-knowledge","Twenty-five years of WWOX insight in cancer: a treasure trove of knowledge","","Over two decades ago, MD Anderson Cancer research identified and characterized WWOX as a tumor suppressor mapped to chromosomal region 16q23.3-24.2. WWOX inhibits oncogenic signaling, including the Wnt/β-catenin pathway, regulating proliferation and apoptosis to limit tumor formation. Restoring WWOX expression in cancer cell lines reduces tumor growth and increases treatment sensitivity. Proteomic and mechanistic studies show interactions with signaling molecules such as Dishevelled and SMAD3 and regulation through proteins and microRNAs affecting adhesion, invasion, and motility, while challenges remain in translating these findings to clinical biomarkers and therapies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/twenty-five-years-of-wwox-insight-in-cancer-a-treasure-trove-of-knowledge/365404/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/twenty-five-years-of-wwox-insight-in-cancer-a-treasure-trove-of-knowledge/365404.png","ImageObject",300,407,{"name":42,"@type":43},"Connor ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is WWOX and where is it located in the genome?","Question",{"text":63,"@type":64},"WWOX is a tumor suppressor gene identified in relation to cancers and mapped to chromosomal region 16q23.3-24.2.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does WWOX suppress tumor development?",{"text":68,"@type":64},"WWOX inhibits pathways such as Wnt/β-catenin, which supports regulation of proliferation and apoptosis to prevent tumor formation.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence supports WWOX as a biomarker for prognosis and treatment response?",{"text":72,"@type":64},"The review summarizes that restoring WWOX expression reduces tumor growth, increases sensitivity to treatments, and that research links WWOX loss or altered expression with clinical processes, while noting that translation to clinical applications still faces challenges.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365404,1790636494,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Functional & Integrative Genomics (2025) 25:100 [https://doi.org/10.1007/s10142-025-01601-5](https://doi.org/10.1007/s10142-025-01601-5)  \nREVIEW  \nTwenty-five years of WWOX insight in cancer: a treasure trove of knowledge  \nRaneemY. Hammouz1 · Izabela Baryła1 · Ewa Styczeń-Binkowska1 · Andrzej K. Bednarek1  \nReceived: 12 November 2024 / Revised: 1 April 2025 / Accepted: 12 April 2025 / Published online: 6 May 2025 © The Author(s) 2025  \nAbstract More than two decades ago, MD Anderson Cancer group discovered, characterised, and identified the WW domain-containing oxidoreductase (WWOX) as a genes of interest mapping to the chromosomal region 16q23.3-24.2 . This was pioneering research since WWOXis a critical tumour suppressor gene implicated in various cancers, involving interactions with numerous signalling pathways and molecular mechanisms. Notably, it inhibits the Wnt/β-catenin pathway, which is often activated in tumours. This inhibition helps prevent tumour formation by regulating cell proliferation and promoting apoptosis. Restoration of WWOX expression in cancer cell lines has been shown to reduce tumour growth and increased sensitivity to treatments. In addition to its role in tumour suppression, WWOX has been found to interact with proteins involved in critical signalling pathways such as TGF-β . Recent advancements allowed to reveal its interactions with key proteins and microRNAs that regulate cellular adhesion, invasion, and motility. Proteomic studies have shown that WWOX directly interacts with signalling molecules like Dishevelled and SMAD3, further underscoring its role in antagonizing metastasis. Challenges remain in translating this knowledge into clinical applications. For instance, the mechanisms underlying WWOX loss in tumours and its role across diverse cancer types require further investigation. Overall, WWOX serves as a vital player in maintaining cellular stability and preventing cancer progression through its multifaceted functions. Here, we include an updated molecular function of WWOXin cancers to possibly contribute to the potential use of WWOX expression as a biomarker regarding prognosis and response to the treatment.  \nClinical trial number Not applicable.  \nKeywords WWOX · Pathways · Biomarker · Expression modulator · LOH · Warburg  \nRelevance  \nWWOX is increasingly acknowledged as a critical tumour suppressor gene and a global expression modulator that affects numerous cellular processes. WWOX was found  \nRaneem Y. Hammouz and Izabela Baryła contributed equally to this work and are first co-authors  \n􀀍 Andrzej K. Bednarek [andrzej.bednarek@umed.lodz.pl](andrzej.bednarek@umed.lodz.pl)  \nRaneem Y. Hammouz  \n[raneem.hamouz@umed.lodz.pl](raneem.hamouz@umed.lodz.pl)  \nIzabela Baryła  \n[izabela.baryla@umed.lodz.pl](izabela.baryla@umed.lodz.pl)  \n[Ewa Stycze](Ewa Stycze)ń[-Binkowska](-Binkowska)  \n[ewa.styczen-binkowska@umed.lodz.pl](ewa.styczen-binkowska@umed.lodz.pl)  \n1 Department of Molecular Carcinogenesis, Medical University of Lodz, Żeligowskiego 7/9, Lodz 90-752, Poland  \nto be frequently associated with various cancers, where it not only acts as tumour suppressor protein but also regulates critical cellular metabolic pathways involved in cancer progression like Warburg effect through HIF1A binding. Notably, WWOX expression is often diminished in tumour tissues but unlike as most tumour suppressor genes, the silencing of both alleles is observed very rarely. Usually, chromosomal changes such as deletions and translocationsat the fragile site FRA16D result as haploinsufficiency phenomenon of WWOX (observed in more than 70% of breast cancers). Interestingly, while many tumours exhibit reduced WWOX expression, this downregulation does not consistently correlate with allele deletions. Research indicates that significant decreases in WWOX mRNA levels can result from mechanisms like hypermethylation and transcriptional regulation, rather than direct genetic loss (Kałuzińska et al. 2021b; Husanie et ","cbCaibf9q4FEGcBC","https://ap.wps.com/l/cbCaibf9q4FEGcBC","pdf",1981960,29,"English","# Abstract\n## Background and discovery\n## Mechanisms in cancer progression\n## Therapeutic relevance and biomarker potential","[{\"question\":\"What is WWOX and where is it located in the genome?\",\"answer\":\"WWOX is a tumor suppressor gene identified in relation to cancers and mapped to chromosomal region 16q23.3-24.2.\"},{\"question\":\"How does WWOX suppress tumor development?\",\"answer\":\"WWOX inhibits pathways such as Wnt/β-catenin, which supports regulation of proliferation and apoptosis to prevent tumor formation.\"},{\"question\":\"What evidence supports WWOX as a biomarker for prognosis and treatment response?\",\"answer\":\"The review summarizes that restoring WWOX expression reduces tumor growth, increases sensitivity to treatments, and that research links WWOX loss or altered expression with clinical processes, while noting that translation to clinical applications still faces challenges.\"}]","Twenty-five years of WWOX insight in cancer: a treasure trove of knowledge | PDF",1790160831,73,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0fdab49f451403866e2d8eea1baadfa.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/094baa54fdd68c0300425f4c09e4ae1f.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9c1a1d0fcd38c3a307cbb1b18fc6113.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/454356a844e4a084ecd71f2986d3a2be.webp",980,1301]